Io Therapeutics, Inc., announces presentation of data from studies of its RAR gamma agonist compound IRX5010 in treatment of a mouse model of triple negative breast cancer, demonstrating combination treatment effects with an anti-PDL-1 monoclonal antibody 12-12-2024, 04:35

Iveco Group announces the results of the Annual General Meeting, the publication of its 2022 Sustainability Report, and the launch of an initial 55 million euro tranche of its share buyback program 14-04-2023, 17:45

Experts Explain Why It's Important for Businesses to Invest 13-02-2023, 04:01